Navire Pharma
Phase 1Navire Pharma is developing SHP2 inhibitors as potentially effective additions to the therapeutic arsenal for difficult-to-treat cancers. Learn more today!
Founded
2015
Focus
Small Molecules
About
Navire Pharma is developing SHP2 inhibitors as potentially effective additions to the therapeutic arsenal for difficult-to-treat cancers. Learn more today!
Funding History
1Total raised: $60M
Series A$60MOrbiMedJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationSan Francisco, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile